|

MDNA11 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Interleukin-2 (IL-2)-albumin

Pipeline

Phase 1/2: 1

Top Sponsors

  • Medicenna Therapeutics, Inc.1

Indications

  • Viral Cancer1
  • Pancreas Adenocarcinoma (MSI-H)1
  • DMMR Solid Malignant Tumor1
  • Cancer With A High Tumor Mutational Burden1
  • MSI-H Solid Malignant Tumor1

San Diego, California1 trial

A Beta-only IL-2 ImmunoTherapY Study

Sharp Memorial Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.